Bivamelagon is under clinical development by Rhythm Pharmaceuticals and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate ...
Whether to fully subsidise the new generation weight loss drugs such as Mounjaro and Ozempic for obese Australians without ...
BG-102 is under clinical development by SL Bigen and currently in Phase II for Obesity. According to GlobalData, Phase II drugs for Obesity have a 29% phase transition success rate (PTSR) indication ...
Which biotechs are most likely to be acquired near-term? We asked Seeking Alpha analysts Edmund Ingham and Terry Chrisomalis for their thoughts on the topic. Read more here.
A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...
Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...
Hosted on MSN8h
Ozempic successfully treats kidney diseaseMore than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...
Patients waiting for NHS weight loss jabs are buying potentially unsafe jabs online or from gyms and beauty salons ...
Are you a worrier? Then perhaps don't read this article. Scientists have proved that the more you worry, the shorter your ...
By Aaron Boxerman Even quaint corners of the country are seeing a rise in drug violence and crime. Just ask the mayor of Morlaix, which has a population of about 15,000. A government push to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback